NCT00000634View on ClinicalTrials.gov

A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children

NACompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

Not specified

Primary Completion Date

June 30, 1995

Conditions

HIV Infections

Interventions

DRUG

Nevirapine

Trial Locations (1)

01605

Univ of Massachusetts Med Ctr / Biotech II, Worcester

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH